In this study, we propose a novel method for inducing neuronal cells by briefly exposing them to small-molecule cocktails in a step-by-step manner. Global gene expression analysis with immunohistochemical staining and calcium flux assays reveal the generation of neurons from mouse embryonic fibroblasts. In addition, time-lapse imaging of neural precursor-specific enhancer expression and global gene expression analyses show that the neurons are generated by passing through a neural crest-like precursor stage. Consistent with these results, the neural crest-like cells are able to differentiate into neural crest lineage cells, such as sympathetic neurons, adipocytes, osteocytes, and smooth muscle cells. Therefore, these results indicate that brief exposure to chemical compounds could expand and induce a substantial multipotent cell population without viral transduction.
crest cells also give rise to glial Schwann cells, melanocytes, endocrine cells, smooth muscle cells, and peripheral neurons. Additionally, in bone marrow or adipose tissues, neural crest cells are the source of mesenchymal stem cells that can differentiate into cartilage, bone, and white adipocytes. The multipotent phenotype and self-renewal capacity of these cells are expected to have potential applications in cell-based therapies [7] . In addition, neural crest cells are related to serious diseases, such as Hansen disease, in which Mycobacterium leprae initially infects Schwann cells, which later dedifferentiate into progenitor/stem-like cells, causing symptoms of granuloma formation, skin lesions, and peripheral nervous system (PNS) damage, including sensory loss.
Treatment with small molecules, such as regulators of specific signaling pathways or epigenetic states, has recently attracted much attention for applications in cell differentiation and induction. Notably, Hou et al. reported that mouse pluripotent stem cells could be generated from somatic cells using only small molecules [8] . These studies have suggested that optimization of small-molecule combinations may facilitate the generation of neuronal cells from neuronal stem cells and non-neuronal cells.
In this study, we proposed a method for production of peripheral neurons and other neural crest-derived cells using only small-molecule compounds. Our results suggested that brief exposure to chemical compounds in a step-by-step manner facilitated rapid cell induction for acquisition of murine multipotent neural crestlike precursors.
Materials and methods

Cell culture
All the procedures were performed in accordance with the guidelines of the National Institute of Advanced Industrial Science and Technology (AIST) Animal Care and Use Committee (approval no.: 2013-186).
Mouse embryonic fibroblasts (MEFs) were isolated from 12.5-day-old embryos of C57BL/6NCrSlc mice. Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% fetal bovine serum (FBS), 1% nonessential amino acids (NEAAs), and 1% penicillin/ streptomycin (PS); these cells were defined as P0 MEFs. To assess the effects of small molecules, we used embryonic fibroblasts from two strains of transgenic mice in which neural and neural crest-derived cells specifically expressed enhanced green fluorescent protein (EGFP) under the control of the promoter/enhancer of the Nestin gene (Nestin-EGFP MEFs [9] ) and under the control of the CAG-CAT-EGFP reporter specifically induced by expression of the Wnt1 promoter-driven Cre recombinase gene (Wnt1-Cre/EGFP MEFs [10] [11] [12] ), respectively. These transgenic strains were supplied by Shinsuke Shibata, Wado Akamatsu, and Hideyuki Okano.
Chemical treatment
To modulate cellular fate, small molecules were applied to the cultured samples. A combination of 0.25 mM valproic acid (VPA; Wako Pure Chemical Industries, Osaka, Japan), 1.5 lM CHIR99021 (CHIR; Cayman Chemical Company, Ann Arbor, MI, USA), 0.5 lM 616452 (Merck Millipore, Darmstadt, Germany), 5 lM forskolin (FSK; Wako Pure Chemical Industries), and 2.5 lM tranylcypromine (Tranyl; Abcam, Cambridge, UK) was used. The cocktail was mixed in DMEM supplemented with 20% FBS, 1% NEAAs, 1% PS, 50 ngÁmL À1 basic fibroblast growth factor (bFGF), and culture supernatants from CHO cells producing leukemia inhibitory factor (LIF), a kind gift from T. Nakano (Osaka University, Japan). The chemical medium was applied to the culture samples for 2 days. Another small-molecule cocktail, composed of 0.25 mM VPA, 5 lM FSK, 2.5 lM Tranyl, 2.5 lM dorsomorphin (DM; Sigma-Aldrich, St. Louis, MO, USA), and 2.5 lM SB431542 (SB; SigmaAldrich), was then applied for 1 day. This small-molecule cocktail was also mixed in DMEM-based medium as described above.
Neuronal differentiation
After exposure to the small-molecule cocktails, cells were cultured in differentiation medium consisting of DMEM/ F-12 (Wako Pure Chemical Industries), 25 lgÁmL À1 insulin (Wako Pure Chemical Industries), 50 lgÁmL À1 human transferrin (Sigma-Aldrich), 30 nM sodium selenite (SigmaAldrich), 20 nM progesterone (Sigma-Aldrich), 100 nM putrescine (Sigma-Aldrich), and 1% PS. For neuronal differentiation, the differentiation medium was further supplemented with 1 lM retinoic acid (RA; Sigma-Aldrich), 10 lM FSK, 10 ngÁmL À1 brain-derived neurotrophic factor (BDNF; Wako Pure Chemical Industries), 10 ngÁmL À1 glial cell-derived neurotrophic factor (GDNF; Wako Pure Chemical Industries), and 50 lgÁmL À1 ascorbic acid (Wako Pure Chemical Industries); this was defined as the neuronal differentiation medium (NDM). Before adding cells, the culture dishes were coated with 20 lgÁmL À1 poly-L-ornithine (PLO; Sigma-Aldrich) for 1 h at 37°C, followed by treatment with 5 lgÁmL À1 laminin (SigmaAldrich) for 2 h at 37°C. The cells were then seeded onto the coated dishes at a density of 5 9 10 4 cellsÁcm
À2
. Half of the NDM was exchanged twice a week to maintain the cultures. Wako Pure Chemical Industries) [13] . EGFP expression was monitored by fluorescence microscopy every day during the chemical treatment for the first 3 days and at day 10.
Adipocyte differentiation
To induce adipocyte differentiation in chemical-treated cells, the chemical medium on day 4 was replaced with differentiation medium supplemented with 10 lM FSK and 5 lM SB. The differentiation medium was changed every 2 days. Table S1 .
Osteocyte differentiation
Microarray analysis
Total RNA extracted from chemical-treated MEFs and control MEFs on day 10 was used for microarray analysis. Total RNA (140 ng) was reverse transcribed and labeled with Cy3 using a Low Input Quick Amp Labelling Kit, One Color (Agilent Technologies, Tokyo, Japan) according to the manufacturer's protocol. Hybridization to the microarrays was performed using a Gene Expression Hybridization Kit (Agilent Technologies) according to the manufacturer's protocol. Expression profiling was performed with a SurePrint G3 Mouse GE microarray 8 9 60 K (Agilent Technologies). An Agilent DNA microarray scanner and Feature Extraction Software were used to determine the fluorescence intensities of spots on the microarray. Samples were run in triplicate. The obtained data were intra-and interarray normalized, and differentially expressed genes with P values of < 0.05 were detected using the limma package [14] in the R statistical computing environment. Gene ontology (GO) and KEGG pathway enrichment analyses were performed in the Database for Annotation, Visualization, and Integrated Discovery (DAVID) [15] . Biological process GO terms having P values of < 0.01 and KEGG pathways having P values of < 0.05 were considered significant. All P values in GO and KEGG pathway enrichment analyses and differential expression analysis were corrected for multiple testing with the Benjamini-Hochberg method. The list of neural crest- related genes used in Fig. 3G was extracted from the GO database ( [16] ; GO:0014032 and GO:0014033) with several genes added from the literature [17, 18] . The list of neuronrelated genes used in Fig. 1C was also obtained from the GO database (GO:0030182 and GO:0048666). The microarray data were deposited in the NCBI Gene Expression Omnibus database, with accession number GSE78890 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=atij cawifrubdqd&acc=GSE78890).
Immunohistochemical analysis
Immunohistochemical staining was performed as previously described [19] . Primary antibodies were added and incubated overnight at 4°C. 
Statistical analysis
All data are expressed as means AE SDs. For qPCR and calcium imaging experiments, statistical analyses were performed using two-tailed unpaired t-tests. For microarray experiments, statistical analyses were carried out as described above. Differences with P values of < 0.05 were considered statistically significant.
Results
For application of small-molecule compounds, we selected seven small molecules based on currently available reprogramming methods [8] : VPA, CHIR, 616452, FSK, Tranyl, DM, and SB. VPA is a histone deacetylase inhibitor that improves cell reprogramming efficiency by combining with transcription factors [25] , whereas CHIR is a glycogen synthase kinase 3 (GSK3) inhibitor that activates Wnt signaling and improves cell reprogramming efficiency [26] . 616452, an inhibitor of TGF-b type 1 activin-like kinase receptor (ALK) 5, can replace the transcription factor SOX2 and enhance NANOG expression [27] . FSK is a cAMP signaling activator that potentiates neuronal differentiation [28] . Additionally, both FSK and Tranyl, a lysine-specific demethylase 1 inhibitor, improve cell reprogramming efficiency [29] . Finally, DM is a bone morphogenic protein (BMP) signaling inhibitor, and SB is an inhibitor of TGF-b type 1 ALK4, ALK5, and ALK7. The combination of DM and SB can efficiently induce neuronal differentiation in human embryonic stem (ES) and induced pluripotent stem (iPS) cells [30] . In this study, we treated the cells with a combination of VPA, CHIR, 616452, FSK, and Tranyl (VC6FT) for 2 days and a combination of VPA, DM, SB, FSK, and Tranyl (VDSFT) for an additional 1 day, followed by differentiation into neuronal cells in differentiation medium (Fig. 1A) . We first performed a comparative gene expression analysis of chemical-treated and control MEFs using global gene expression profiles measured by microarrays. From a global point of view, a total of 6780 upregulated and 7093 downregulated genes were identified (P < 0.05; Fig. 1B) . Interestingly, the top 50 upregulated genes included neuron-associated genes, such as Agtr2, Lgr5, Ptgds, and Aqp4. In contrast, the top 50 downregulated genes included cell cycle-and proliferation-associated genes, such as Ptgs2 and Thbs4, and the fibroblast-associated Acta2 gene. Furthermore, microarray-based transcriptome analysis confirmed the upregulation of various neural differentiation-and development-related markers (Fig. 1C) . Thus, the small molecule-based culture method strongly affected cell identity and specifically induced neural differentiation and development-related genes.
Neural differentiation from chemical-treated MEFs
Next, we attempted to identify the neuronal differentiation capability of the chemical-treated MEFs. As expected, these cells were positive for TUJ1, synapsin-1, MAP2, and NeuN at several days after treatment ( Fig. 2A) , indicating that the chemical treatment protocol caused induction of neuronal cells. In addition, RT-qPCR analysis showed that the expression levels of typical marker genes for neuronal lineages, such as Ascl1, Brn2, and Map2, were significantly elevated in the induced cells, in contrast with those in untreated cells (Fig. 2B) . Incidentally, there were no MAP2-positive neurons generated without chemical treatment from control MEFs (Fig. 2C) .
We also confirmed the neuronal activities of the generated cells using calcium imaging. Notably, no distinct spontaneous activity was detected in the control samples (Movie S1). In contrast, spontaneous calcium transients with onset and decay occurring within 20 s were observed in the chemical-treated cells (Fig. 2D , Movie S2). Traces of calcium transients in selected cells (arrows in Fig. 2D ) are shown in Fig. 2E . Analysis of the calcium activity in the chemical-treated cells revealed significantly increased activity following application of 50 mM potassium (High K + ) saline solution compared with that in Ringer's solution (Fig. 2E,F) . Notably, the induced neurons exhibited spontaneous calcium activity having a certain duration, which was relatively slow for central nervous system (CNS) neurons (within several seconds), but consistent with PNS neurons [31] . Thus, the generated neurons were thought to be peripheral neurons.
Chemical compounds induced the transdifferentiation of MEFs into neural crest-like lineages
To investigate the induction process involved in neuron generation, we focused on marker gene expression during this process. The Nestin gene is known to be expressed in neural progenitor cells and neural crest stem cells [32, 33] . Therefore, we first examined changes Moreover, we monitored EGFP fluorescence using MEFs derived from double transgenic mice harboring EGFP with Wnt1 gene regulatory regions (Wnt1-Cre/ EGFP MEFs) [7] [8] [9] to examine whether the induced cells were neural crest cells. The Wnt signaling pathway is involved in early specification of SOX10-or paired box 3 (PAX3)-positive neural crest cells during the embryonic stage [24] . Similar to those in Nestin-EGFP MEFs, Wnt1-Cre/EGFP MEFs also intrinsically include a small population of EGFP-positive cells. Although the number of EGFP-positive cells and the intensity of pre-existing EGFP-positive cells were the same as those in controls during the 72-h chemical treatment, the fluorescence was dramatically increased after continuous culture in neural crest maintenance medium at day 10 (Fig. 3C) . After the chemical treatment, the rate of EGFP-positive cells increased to 9.4% AE 4.5%. To evaluate whether the induced cells were neural crestlike precursors, we examined SOX10 expression by immunohistochemical staining. The number of SOX10-positive cells increased about twofold in step-by-step chemical treatment compared with that in the control samples (Fig. 3D) . We also examined double staining of Wnt1 and SOX10 and confirmed that about 40% of EGFP-positive cells were positive for SOX10 (Fig. S3) . These results indicated that the chemical treatment drove Nestin gene expression, induced Wnt1 gene expression, and caused MEFs to develop into SOX10-positive neural crest-like precursors.
As described above, Nestin-EGFP and Wnt1-Cre/ EGFP MEFs intrinsically included a small population of weakly EGFP-positive cells at the start of each experiment. Moreover, the induced neural crest-like cells already lost the capacity for self-renewability in the conventional neural crest maintenance medium (data not shown), showing downregulation of cell cycle-and proliferation-associated genes, such as Ptgs2 and Thbs4 (Fig. 1B) . Thus, these data suggested that the positive expression status of some of neural crest markers, such as Sca-1, P75NTR, and Sox10, in response to our chemical treatment indicated the transient move toward the neuronal differentiation.
Based on the above results, we performed a time series RT-qPCR profiling experiment using the induced cells on days 0 (as a control), 2, 4, 6, and 10 with step-by-step chemical treatment. The expression levels of neural crest markers, including P75 ntr (also known as Ngfr), Pax3, Foxd3, and Sca-1 (also known as Ly6a) [23, 34] , were significantly elevated (Fig. 3E  and Fig. S1 ). Interestingly, the expression levels of CNS neural stem cell markers, including Pax6 and Sox2 [35] , were not elevated during the chemical treatment (Fig. S2) . Additionally, GO and KEGG pathway enrichment analyses for upregulated genes measured by microarrays are shown in Fig. 3F . These analyses revealed that several affected terms and pathways were related to neural differentiation and development. Specifically, microarray-based transcriptome analysis confirmed the upregulation of various neural crest-related markers (Fig. 3G) . Taken together, our 
Chemical-treated MEFs differentiated into neural crest derivatives
To confirm the differentiation capacity of the induced neural crest-like precursors, we examined whether the induced cells could differentiate into peripheral neurons, adipocytes, osteocytes, and smooth muscle cells, which are characteristic lineages of neural crest-derived cells [23] . As expected, most TUJ1-or MAP2-positive cells coexpressed peripherin (Fig. 4A) , indicating that induced neurons were predominantly peripheral neurons. Interestingly, several MAP2-positive cells coexpressed the gene encoding TH, which is a marker of sympathetic neurons in peripheral neurons on day 35 (right panels in Fig. 4A ). Additionally, after 1 week of culture in adipose differentiation medium, lipid droplet-like structures were observed (Fig. 4B) , and the expression levels of the adipocyte marker (Adipoq) and fatty-acid-binding protein 4 (Fabp4) were elevated (Fig. 4C) . For osteocyte differentiation, differentiated osteocytes were monitored by Alizarin red staining (Fig. 4D) . Finally, smooth muscle cell differentiation was observed by analysis of aSMA expression (Fig. 4E) . Taken together, these findings suggested that step-by-step chemical treatment rapidly and transiently induced neural crest-like precursors. 
Discussion
In this study, we evaluated the mechanisms through which neural crest-like cells are induced following exposure to the proposed step-by-step chemical cocktails. Hou et al. reported that the combination of VPA, CHIR, 616452, FSK, and Tranyl significantly induced pluripotency-related genes in fibroblasts [8] , suggesting that brief exposure to these small-molecule cocktails induced partial reprogramming of cells. However, the combination of a GSK3 inhibitor, a TGF-b/ activin/nodal inhibitor, and a BMP inhibitor has been shown to be useful for induction of neural crest lineage cells from ES or iPS cells [17, 36] . In these reports, CHIR and (2 0 Z,3 0 E)-6-bromoindirubin-3 0 -oxime (BIO) were used as GSK3 inhibitors, SB was used as an inhibitor of TGF-b/activin/nodal, and LDN-193189 and Noggin were used as BMP inhibitors. For the small molecules used in this paper, VPA, FSK, and Tranyl are thought to function in partial reprogramming or as a supportive reagent [25, 28, 29] . Furthermore, other small molecules (the GSK3 inhibitor CHIR, the BMP inhibitor DM, and the TGF-b/activin/nodal inhibitor SB) are used for inducing NCCs from ES or iPS cells, as described above. Based on this knowledge, we believe that our chemical treatment protocol partially reverted MEFs to a pluripotent state by affecting VPA, FSK, and Tranyl; additionally, the regulation of cellular fate to the neural crest lineage was affected by CHIR, DM, and SB. Moreover, our proposed culture conditions may simultaneously facilitate selective expansion and proliferation of na€ ıve neural crest cells that are intrinsically present in the obtained tissues. In either case, our proposed protocol is useful for obtaining neural crest-like precursors and their derivatives.
Gene delivery techniques are commonly used for cell reprogramming and conversion. However, the drawbacks of viral transduction, including integration of exogenous genes into the target cells, may limit the application of virus-based methods in therapeutic approaches. Here, we proposed a method for treatment of cells with small-molecule cocktails and confirmed the generation of peripheral neuronal cells from somatic cells. Although small molecule-based induction of specific cell types has been recently reported for neurons [37] [38] [39] , pancreatic cells [40] , and Schwann cells [41] , induction of neural crest-like precursors and its derivatives have only been reported using a Sox10 gene-transfer method [42] . One of the most important features of step-by-step chemical treatment is the rapid treatment protocol. We could induce MAP2-positive neuronal cells from somatic cells within 10 days, in contrast to chemically iPS cells, which required over 1 month [8] . Rapid production of neurons is a key factor required for cell transplantation and regenerative medicine and is necessary to avoid inflammation, which may induce glial scars and inhibit neuroregeneration [43, 44] . On the other hand, the induction rate in the experiments is rather low efficiency for further application. Differentiation, transdifferentiation, and reprogramming efficiency depend on many unknown factors, such as cell identity, including cell cycle status, circadian, and epigenetics, as well as the heterogeneity of MEFs. By identifying the mechanisms involved in the process with small molecules, we will increase the induction efficiency. Therefore, we anticipate that modified methods for inducing human peripheral neurons and other neural crest derivatives using small molecules only will be developed in the near future to improve therapeutic approaches.
Conclusion
Here, we performed a step-by-step treatment of smallmolecule cocktails to induce neuronal cells from somatic cells. We observed the generation of MAP2-and NeuN-positive neurons from MEFs. Gene expression profiling revealed that the small-molecule treatment induced neural crest-like precursors; thus, the induced neurons were neural crest-derived PNS neurons. Small molecules have significant advantages in terms of cell permeability, nonimmunogenicity, and ease of handling using standardized protocols. Thus, our induction method in mouse cells is a safe, promising approach that may contribute to the development of therapeutic applications in human cells. On the other hand, our step-by-step induction method includes the use of various epigenetic and signaling modulators, and its complex interactions. Thus, in the present, we cannot rule out the potent risks of various cell damages, senescence, or cancerization. Ensuring the safety and viability of induced cells with the use of other simplified combinations of small molecules will be required for further therapeutic applications.
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